HeartFlow

HeartFlow is a pioneering medical technology company dedicated to revolutionizing precision heart care through advanced artificial intelligence and computational fluid dynamics. Founded in 2007, the company has developed a novel, non-invasive approach to diagnose and manage coronary artery disease (CAD), transforming patient outcomes and healthcare professional workflows. Their proprietary technology analyzes medical imaging data to create a personalized, three-dimensional, dynamic digital model of a patient's heart, providing critical insights without the need for invasive procedures. This AI-driven platform represents a significant leap forward in cardiovascular diagnostics, offering best-in-class solutions for healthcare providers.

Operating with an employee range of 500 - 1,000 individuals, HeartFlow is committed to innovation and excellence in the healthcare technology sector. The company's mission-driven approach focuses on leveraging human ingenuity and cutting-edge technology to address complex medical challenges. Their work in digital health and personalized medicine positions them as a leader in the field, aiming to improve the standard of care for millions of patients worldwide. Meet HeartFlow's team to understand the expertise driving their advancements.

With a reported revenue of $176.0M, HeartFlow demonstrates significant market presence and financial traction. The company has secured substantial funding rounds, underscoring investor confidence in its disruptive technology and growth potential. Their focus on diagnostic software and AI-driven healthcare solutions addresses a critical need in the market for more effective and accessible cardiovascular disease management. Explore financial highlights for detailed performance metrics and investment history.